WuXi STA tapped as preferred partner for Beta Pharma
WuXi STA becomes the preferred CDMO partner for Beta Pharma as the company launches a Phase II clinical trial in China and begins preclinical research for an additional target.
Archives for March 21, 2019
DEA license offers Cure hemp-based CBD manufacturing
Cure Pharma expands its DEA license to include authorization to manufacture both cannabis plant extracts and CBD within the scope of its patent portfolio.
BlueCloud follows the Uber model to streamline connections
BlueCloud by HealthCarePoint releases DDIT mechanisms to create an Uber-like service for the health care industry – connecting providers and consumers, such a sponsors and CROs.
Expansion of Cambrex’s Milan site makes room for APIs
Cambrex completes expansion of its R&D laboratory at its Milan site and adds a 12,000-liter reactor to its manufacturing facility during a $3m investment.
Synteract opening a new office, hiring for several positions as demand increases
Synteract is opening a new office in Swansea, Wales in response to increased demand across its core therapeutic areas for both full-service work and more consultative, standalone projects, says CEO.
WCG launches new solution aimed at easing clinical trial site burden
WCG’s new SiteReady solution looks to alleviate the challenges facing research teams, helping clinical trial sites remain “highly ranked” with sponsors.
CRF Bracket updates eConsent solution to support virtual studies
CRF Bracket’s eConsent solution now supports remote consenting – as the demand for virtual clinical trials has increased steadily over recent years.